Clinical Trial Update: Stereotactic Body Radiation Therapy Plus Immediate or Delayed Androgen Receptor Pathway Inhibitor and Androgen Deprivation Therapy or Salvage Radiation Therapy for the Treatment of Prostate Cancer, DIVINE Trial [Phase 2]

View source ↗

Summary

DIVINE is a Phase 2 trial evaluating stereotactic body radiation therapy with either immediate or delayed androgen receptor pathway inhibitor and androgen depri…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biochemically Recurrent Prostate Cancer
• Castration-resistant Prostate Cancer
• Castration-sensitive Prostate Cancer
• Prostate Cancer

Drugs mentioned

• Androgen deprivation therapy (Androgen deprivation therapy)
• Androgen receptor pathway inhibitor (androgen receptor pathway inhibitor)

Snippet

Sponsor: Mayo Clinic | Conditions: Recurrent Castration-Sensitive Prostate Carcinoma, Recurrent Prostate Cancer | Phase 2 | Status: RECRUITING